TABLE 1.
Tumor markers | CKD | Significance | References | |
---|---|---|---|---|
Non-dialysis | On dialysis | |||
CEA | H | H | Monitoring for malignancy in uremic patients might be unreliable | Tzitzikos et al., 2010; Cases et al., 1991; Rani et al., 2019 |
SCC | H | H | Monitoring for malignancy in uremic patients might be unreliable | Cases et al., 1991; Xiaofang et al., 2007 |
CA50 | H | H | Monitoring for malignancy in uremic patients might be unreliable | Cases et al. (1991) |
NSE | H | H | Monitoring for malignancy in uremic patients might be unreliable | Cases et al., 1991; Xiaofang et al., 2007 |
CA125 | N or H | N | Monitoring for malignancy in dialysis patients might be unreliable | Cases et al., 1991; Mikkelsen et al., 2017 |
CA153 | N or H | N or H | Monitoring for malignancy in uremic patients might be controversial | Cases et al., 1991; Xiaofang et al., 2007; Rani et al., 2019; Tzitzikos et al., 2010 |
CA199 | N or H | N | Monitoring for malignancy in uremic patients might be comparatively reliable | Cases et al., 1991; Xiaofang et al., 2007; Rani et al., 2019; Mikkelsen et al., 2017 |
CA724 | N | N | Monitoring for malignancy in dialysis patients might be reliable in dialysis patients | Xiaofang et al. (2007) |
CYFRA21-1 | H | — | Monitoring for malignancy in uremic patients might be possibly unreliable | Xiaofang et al., 2007; Mikkelsen et al., 2017 |
HCG | H | — | Monitoring for malignancy in uremic patients might be possibly unreliable | Rani et al. (2019) |
PSA | N | N | Monitoring for malignancy in uremic patients might be possibly reliable | Cases et al. (1991) |
AFP | N | N | Monitoring for malignancy in uremic patients might be reliable | Tzitzikos et al., 2010; Cases et al., 1991; Xiaofang et al., 2007 |
PAP | N | N | Monitoring for malignancy in uremic patients might be possibly reliable | Cases et al. (1991) |
CGA | H | — | Monitoring for malignancy in uremic patients might be possibly unreliable | Mikkelsen et al. (2017) |
H = high serum level; N = normal serum level.